LONDON and PHILADELPHIA – November 2, 2026 – Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a life sciences company developing innovative, targeted oncology drugs, today announces that Christina Coughlin, CEO and Brian Hahn, CFO will be attending the Jefferies Global Healthcare Conference and hosting one-on-one meeting with investors. The conference is taking place in London from November 16-19, 2026.
Interested parties are invited to contact Avacta via the conference partnering system to arrange a one-on-one meeting during the event.